Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 USD | -0.99% | -12.94% | -29.58% |
10/05 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
10/05 | PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.58% | 13Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
-12.64% | 2.22TCr | |
+0.44% | 2.23TCr | |
-4.18% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+37.41% | 1.25TCr | |
-23.95% | 834.13Cr |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- B. Riley Lifts Price Target on PDS Biotechnology to $12 From $10, Cites Higher Probability of Success for Triplet Regimen; Buy Kept